Back to Search
BENJAMIN FLECK, PHARMD
PHARMD
Pharmacist
NPI: 1750726642Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
03124614-1(OH)
Research & Publications (20)
Evidence that the Arabidopsis nuclear gibberellin signalling protein GAI is not destabilised by gibberellin.
PMID 12492836·Plant J·2002
8-other
The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations.
PMID 19515646·Br J Ophthalmol·2010
1-meta
Digital image analysis of plus disease in retinopathy of prematurity.
PMID 19210329·Acta Ophthalmol·2009
6-review
Wide-field digital retinal imaging versus binocular indirect ophthalmoscopy for retinopathy of prematurity screening: a two-observer prospective, randomised comparison.
PMID 19028742·Br J Ophthalmol·2009
4-observational
Rhegmatogenous retinal detachment in Scotland: research design and methodology.
PMID 19317907·BMC Ophthalmol·2009
8-other
Feasibility of saccadic vector optokinetic perimetry: a method of automated static perimetry for children using eye tracking.
PMID 19560207·Ophthalmology·2009
8-other
Systematic review of digital imaging screening strategies for retinopathy of prematurity.
PMID 19171594·Pediatrics·2009
8-other
Retinopathy of prematurity in small-for-gestational age infants compared with those of appropriate size for gestational age.
PMID 18786959·Arch Dis Child Fetal Neonatal Ed·2009
4-observational
Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.
PMID 18445525·Bioorg Med Chem Lett·2008
8-other
Incidence of retinopathy of prematurity in Lothian, Scotland, from 1990 to 2004.
PMID 18463118·Arch Dis Child Fetal Neonatal Ed·2008
4-observational
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.
PMID 18417348·Bioorg Med Chem·2008
7-preclinical
Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.
PMID 18954038·J Med Chem·2008
7-preclinical
Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.
PMID 18954981·Bioorg Med Chem Lett·2008
8-other
Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.
PMID 18468895·Bioorg Med Chem Lett·2008
8-other
Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).
PMID 18550369·Bioorg Med Chem Lett·2008
8-other
Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.
PMID 18667309·Bioorg Med Chem Lett·2008
8-other
Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.
PMID 18672364·Bioorg Med Chem Lett·2008
8-other
Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.
PMID 18294847·Bioorg Med Chem Lett·2008
7-preclinical
Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
PMID 18682322·Bioorg Med Chem Lett·2008
4-observational
Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.
PMID 18539031·Bioorg Med Chem Lett·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3887 MAIDENS LARNE DR
COLUMBUS, OH 43221 - Phone
- (614) 404-5303
Quick Facts
- NPI
- 1750726642
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile